Endophenotype

Endophenotype is a genetic epidemiology term which is used to separate behavioral symptoms into more stable phenotypes with a clear genetic connection. The concept was coined by Bernard John and Kenneth R. Lewis in a 1966 paper attempting to explain the geographic distribution of grasshoppers. They claimed that the particular geographic distribution could not be explained by the obvious and external "exophenotype" of the grasshoppers, but instead must be explained by their microscopic and internal "endophenotype."[1]

The next major use of the term was in psychiatric genetics, to bridge the gap between high-level symptom presentation and low-level genetic variability, such as single nucleotide polymorphisms.[2] It is therefore more applicable to more heritable disorders, such as bipolar disorder and schizophrenia.[3] Since then, the concept has expanded to many other fields, such as the study of ADHD,[4] addiction,[5] Alzheimer's disease[6] obesity[7] and cystic fibrosis.[8] Some other terms which have a similar meaning but do not stress the genetic connection as highly are "intermediate phenotype", "biological marker", "subclinical trait", "vulnerability marker", and "cognitive marker".[9][10] The strength of an endophenotype is its ability to differentiate between potential diagnoses that present with similar symptoms.[11]

Definition

In psychiatry research, the accepted criteria which a biomarker must fulfill to be called an endophenotype include:[2][12][13]

  1. An endophenotype must segregate with illness in the population.
  2. An endophenotype must be heritable.
  3. An endophenotype must not be state-dependent (i.e., manifests whether illness is active or in remission).
  4. An endophenotype must co-segregate with illness within families.
  5. An endophenotype must be present at a higher rate within affected families than in the population.
  6. An endophenotype must be amenable to reliable measurement, and be specific to the illness of interest.

For schizophrenia

In the case of schizophrenia, the overt symptom could be a psychosis, but the underlying phenotypes are, for example, a lack of sensory gating and a decline in working memory. Both of these traits have a clear genetic component and can thus be called endophenotypes.[2] A strong candidate for schizophrenia endophenotype is prepulse inhibition, the ability to inhibit the reaction to startling stimuli.

Some distinct genes that could underlie certain endophenotypic traits in schizophrenia include:

For bipolar disorder

In bipolar disorder, one commonly identified endophenotype is a deficit in face emotion labeling, which is found in both individuals with bipolar disorder and in individuals who are "at risk" (i.e., have a first degree relative with bipolar disorder).[11] Using fMRI, this endophenotype has been linked to dysfunction in the dorsolateral and ventrolateral prefrontal cortex, anterior cingulate cortex, striatum, and amygdala.[17] A polymorphism in the CACNA1C gene coding for the voltage-dependent calcium channel Cav1.2 has been found to be associated with deficits in facial emotion recognition.[18]

For suicide

The endophenotype concept has also been used in suicide studies. Personality characteristics can be viewed as endophenotypes that may exert a diathesis effect on an individual's susceptibility to suicidal behavior. Although the exact identification of these endophenotypes is controversial, certain traits such as impulsivity and aggression are commonly cited risk factors.[19] One such genetic basis for one of these at-risk endophenotypes has been suggested in 2007 to be the gene coding for the serotonin receptor 5-HT1B, known to be relevant in aggressive behaviors.[20]

See also

References

  1. ↑ John, Bernard; Kenneth R. Lewis (1966). "Chromosome Variability and Geographic Distribution in Insects". Science. doi:10.1126/science.152.3723.711. Retrieved 22 April 2012.
  2. 1 2 3 Gottesman, Irving; Gould, Todd (April 2003). "The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions". The American Journal of Psychiatry. 160 (4): 636–45. doi:10.1176/appi.ajp.160.4.636. PMID 12668349. Retrieved 22 April 2012.
  3. ↑ Greenwood, Tiffany (2007). "Initial Heritability Analyses of Endophenotypic Measures for Schizophrenia". Arch Gen Psychiatry. 64 (11): 1242–50. doi:10.1001/archpsyc.64.11.1242. PMID 17984393. Retrieved 22 April 2012.
  4. ↑ Alderson, R.M., Rapport, M.D., Hudec, K.L., Sarver, D.E., & Kofler, M.J. (2010). Competing core processes in attention-deficit/hyperactivity disorder (ADHD): Do working memory deficiencies underlie behavioral inhibition deficits? Journal of Abnormal Child Psychology, 38, 497-507>
  5. ↑ Karen D. Ersche, P. Simon Jones, Guy B. Williams, Abigail J Turton, Trevor W. Robbins, and Edward T. Bullmore (Feb 3, 2012). "Abnormal Brain Structure Implicated in Stimulant Drug Addiction". Science. 335 (6068): 601–4. doi:10.1126/science.1214463. PMID 22301321.
  6. ↑ Reitz, C (2009). "Endophenotypes in normal brain morphology and Alzheimer's disease: a review". Neuroscience. 164 (1): 174–90. doi:10.1016/j.neuroscience.2009.04.006. PMC 2812814Freely accessible. PMID 19362127.
  7. ↑ Comuzzie, Anthony (2001). "The Genetic Basis of Plasma Variation in Adiponectin, a Global Endophenotype for Obesity and the Metabolic Syndrome". The Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.86.9.4321.
  8. ↑ Frauke, Stanke (2011). "An association study on contrasting cystic fibrosis endophenotypes recognizes KRT8 but not KRT18 as a modifier of cystic fibrosis disease severity and CFTR mediated residual chloride secretion". BMC Medical Genetics. doi:10.1186/1471-2350-12-62.
  9. ↑ Lenzenweger MF (2013). "Endophenotype, intermediate phenotype, biomarker: Definitions, concept comparisons, clarifications". Depression and Anxiety. 30: 185–189. doi:10.1002/da.22042. PMID 23325718.
  10. ↑ Lenzenweger MF (2013). "Thinking clearly about the endophenotype-intermediate phenotype-biomarker distinctions in developmental psychopathology research". Development and Psychopathology. 25: 1347–1357. doi:10.1017/S0954579413000655. PMID 24342844.
  11. 1 2 Brotman, Melissa (2008). "Facial Emotion Labeling Deficits in Children and Adolescents at Risk for Bipolar Disorder". Am J Psychiatry. doi:10.1176/appi.ajp.2007.06122050.
  12. ↑ Gershon ES, Goldin LR (1986). "Clinical methods in psychiatric genetics, I: robustness of genetic marker investigative strategies". Acta Psychiatr Scand. 74 (2): 113–118. doi:10.1111/j.1600-0447.1986.tb10594.x. PMID 3465198.
  13. ↑ Beauchaine, TP (2009). "The role of biomarkers and endophenotypes in prevention and treatment of psychopathological disorders". Biomarkers in Medicine. 3: 1–3. doi:10.1111/j.1540-5834.2009.00509.x.
  14. ↑ Wedenoja J, Loukola A, Tuulio-Henriksson A, Paunio T, Ekelund J, Silander K, Varilo T, Heikkilä K, Suvisaari J, Partonen T, Lönnqvist J, Peltonen L (July 2008). "Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families". Mol. Psychiatry. 13 (7): 673–84. doi:10.1038/sj.mp.4002047. PMID 17684500.
  15. 1 2 Watanabe A, Toyota T, Owada Y, et al. (November 2007). "Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype". PLoS Biol. 5 (11): e297. doi:10.1371/journal.pbio.0050297. PMC 2071943Freely accessible. PMID 18001149.
  16. ↑ Leiser SC, Bowlby MR, Comery TA, Dunlop J (2009). "A cog in cognition: How the alpha7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits". Pharmacology and Therapeutics. 122 (3): 302–11. doi:10.1016/j.pharmthera.2009.03.009. PMID 19351547.
  17. ↑ Rosen, H (2010). "Neurocognitive correlates of emotional stimulus processing in pediatric bipolar disorder: a review.". Postgrad Med. 122 (4): 94–104. doi:10.3810/pgm.2010.07.2177. PMID 20675973.
  18. ↑ Soeiro-de-Souza, Marcio (2012). "The impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolardisorder subjects and healthy controls". Journal of Affective Disorders. doi:10.1016/j.jad.2012.03.014.
  19. ↑ Dwivedi, Y (2012). The Neurobiological Basis of Suicide. Boca Raton: CRC Press.
  20. ↑ Zouk H, McGirr A, Lebel V, Benkelfat C, Rouleau G, Turecki G (December 2007). "The effect of genetic variation of the serotonin 1B receptor gene on impulsive aggressive behavior and suicide". Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B (8): 996–1002. doi:10.1002/ajmg.b.30521. PMID 17510950.
This article is issued from Wikipedia - version of the 6/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.